Skip to search formSkip to main contentSkip to account menu

NSC 281272

Known as: NSC-281272 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

fazarabine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Phase I Clinical Trial of Fazarabine as a Twenty-four-Hour Continuous Infusion 1
A phase I trial of fazarabine (araAC, l-0-D-arabinofuranosyl-5-azaeytusine, NSC 281272) administered as a 24-h continuous… 
1995
1995
A Phase II Study of Fazarabine (NSC 281272) In Patients with Advanced Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
Promising preclinical data and reasonable toxicity in Phase I trials encouraged the Gynecologic Oncology Group to study… 
1993
1993
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate
SummaryArabinosyl-5-azacytosine (AAC), a new nucleoside antimetabolite, is broadly active in preclinical tumor screening… 
1993
1993
Phase II study of fazarabine (NSC 281272) in patients with metastatic colon cancer
SummaryFazarabine (Arabinofuranosyl-5-azacytosine) is a synthetic pyrimidine nucleoside which combines the arabinose sugar of… 
1991
1991
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusion.
A phase I trial of fazarabine (ara-AC, 1-beta-D-arabinofuranosyl-5-azacytosine, NSC 281272) administered as a 24-h continuous… 
1990
1990
Phase I and pharmacokinetic study of arabinofuranosyl-5-azacytosine (fazarabine, NSC 281272).
A Phase I clinical trial of 1-beta-D-arabinofuranosyl-5-azacytosine (ara-AC or fazarabine) given as a 72-h continuous infusion on… 
1989
1989
Phase I trial and pharmacokinetic evaluation of fazarabine in children.
A phase I trial of fazarabine (1-beta-D-arabinofuranosyl-5-azacytosine, NSC 281272) administered as a 24-h continuous infusion… 
1984
1984
Development of an intravenous formulation for the unstable investigational cytotoxic nucleosides 5‐azacytosine arabinoside (NSC 281272) and 5‐azacytidine (NSC 102816)
In aqueous solutions 5‐azacytosine arabinoside (aza‐A) (NSC 281272) exhibits complex and rapid degradation of a type analogous to… 
1983
1983
Furanosyl-5-azacytosine (nsc 281272). Abstr.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)